128 related articles for article (PubMed ID: 29474159)
21. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
[TBL] [Abstract][Full Text] [Related]
22. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia.
Shabani M; Asgarian-Omran H; Jeddi-Tehrani M; Vossough P; Faranoush M; Sharifian RA; Toughe GR; Kordmahin M; Khoshnoodi J; Roohi A; Tavoosi N; Mellstedt H; Rabbani H; Shokri F
Tumour Biol; 2007; 28(6):318-26. PubMed ID: 18354269
[TBL] [Abstract][Full Text] [Related]
24. [Down-regulation of receptor-tyrosine-kinase-like orphan receptor 1 suppresses cell growth and enhances apoptosis in human colorectal carcinoma].
Ma W; He X; Zhang H; Liu T; Feng X; Zhou Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):655-9, 665. PubMed ID: 27126945
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.
Yang J; Baskar S; Kwong KY; Kennedy MG; Wiestner A; Rader C
PLoS One; 2011; 6(6):e21018. PubMed ID: 21698301
[TBL] [Abstract][Full Text] [Related]
26. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
27. Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition.
Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W
J Mol Recognit; 2013 Sep; 26(9):432-8. PubMed ID: 23836471
[TBL] [Abstract][Full Text] [Related]
28. [Prokaryotic expression of human GITRaa27-165 and preparation of its polyclonal antibody].
Tong J; Wang SJ; Chen J; Mao CM; Yang YL; Yang M; Hu ZJ; Zhi DY; Xu HX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):243-6. PubMed ID: 18328184
[TBL] [Abstract][Full Text] [Related]
29. [The Construction of ROR1 Targeting Chimeric Antigen Receptor Modified T Cells and Its Killing Effect for ROR1-positive Tumor Cells].
Chen Y; Mo ZM; Qin DY; Guo FC; Liao XL; Hu M; Chen Q; Wang YS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):145-151. PubMed ID: 31106530
[TBL] [Abstract][Full Text] [Related]
30. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
Saleh RR; Antrás JF; Peinado P; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Cancer Treat Rev; 2019 Jul; 77():11-19. PubMed ID: 31174180
[TBL] [Abstract][Full Text] [Related]
32. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.
Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Int J Cancer; 2008 Sep; 123(5):1190-5. PubMed ID: 18546292
[TBL] [Abstract][Full Text] [Related]
33. ROR1 and ROR2-novel targets for neuroblastoma.
Dave H; Butcher D; Anver M; Bollard CM
Pediatr Hematol Oncol; 2019 Sep; 36(6):352-364. PubMed ID: 31441359
[No Abstract] [Full Text] [Related]
34. Overexpression of proCOL11A1 as a stromal marker of breast cancer.
Fuentes-Martínez N; García-Pravia C; García-Ocaña M; Menéndez-Rodríguez P; Del Amo J; Suárez-Fernández L; Galván JA; De los Toyos JR; Barneo L
Histol Histopathol; 2015 Jan; 30(1):87-93. PubMed ID: 25005174
[TBL] [Abstract][Full Text] [Related]
35. Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1.
Choi MY; Widhopf GF; Wu CC; Cui B; Lao F; Sadarangani A; Cavagnaro J; Prussak C; Carson DA; Jamieson C; Kipps TJ
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl(0):S167-9. PubMed ID: 26297272
[TBL] [Abstract][Full Text] [Related]
36. [Preparation and application of rabbit anti-mouse Setd8 polyclonal antibody].
Ma H; Guo J; Xia J; Niu C; Shen X; Sun H; Zheng Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):246-51. PubMed ID: 29763214
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.
Yin Z; Gao M; Chu S; Su Y; Ye C; Wang Y; Pan Z; Wang Z; Zhang H; Tong H; Zhu J
Oncotarget; 2017 Nov; 8(55):94210-94222. PubMed ID: 29212222
[TBL] [Abstract][Full Text] [Related]
38. [Preparation and characterization of anti-Amelotin polyclonal antibody].
Sun Y; Zhang JJ; Han TT; Li DL; Cao XM; Li WX; Gao YG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):328-31. PubMed ID: 19351503
[TBL] [Abstract][Full Text] [Related]
39. Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis.
Gentile A; Lazzari L; Benvenuti S; Trusolino L; Comoglio PM
Cancer Res; 2011 Apr; 71(8):3132-41. PubMed ID: 21487037
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
